Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirme...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
China-based Baird Medical Investment Holdings, a market leader in minimally invasive Microwave Ablation (MWA) technology...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuou...
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 c...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Palo Alto‑based PGxAI, a leader in AI-powered pharmacogenomics, and Saudi Arabia’s Novo Genomics ...
Japan-based companies Otsuka Pharmaceutical Co. and Towa Pharmaceutical Co. have entered into an agreement to establish ...
South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a...
Singapore based HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced ...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary soluti...
Japan-based pharmaceutical firm Daiichi Sankyo has further established its presence in Canada with the official opening ...
GSK plc and Shionogi & Co. have reached an agreement together with Pfizer Inc. for the 11.7% economic interest in UK...
US-based Pacira BioSciences, Inc. has entered into an agreement with South Korea's LG Chem designed to expand access to ...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...
US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
